Growth Metrics

Edwards Lifesciences (EW) Free Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 7.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.72%
Dec 31, 2025 18.23%
Sep 30, 2025 27.34%
Jun 30, 2025 -5.90%
Mar 31, 2025 0.57%
Dec 31, 2024 -37.94%
Sep 30, 2024 -13.98%
Jun 30, 2024 -14.44%
Mar 31, 2024 -37.70%
Dec 31, 2023 -44.76%
Sep 30, 2023 46.71%
Jun 30, 2023 -28.39%
Mar 31, 2023 26.46%
Dec 31, 2022 -13.58%
Sep 30, 2022 -11.54%
Jun 30, 2022 1.48%
Mar 31, 2022 95.05%
Dec 31, 2021 6.45%
Sep 30, 2021 22.36%
Jun 30, 2021 73.54%
Mar 31, 2021 21.63%
Dec 31, 2020 -2.79%
Sep 30, 2020 -25.10%
Jun 30, 2020 -3.44%
Mar 31, 2020 2.64%
Dec 31, 2019 94.99%
Sep 30, 2019 12.90%
Jun 30, 2019 21.77%
Mar 31, 2019 -35.95%
Dec 31, 2018 15.20%
Sep 30, 2018 20.75%
Jun 30, 2018 -21.71%
Mar 31, 2018 27.22%
Dec 31, 2017 50.08%
Sep 30, 2017 97.04%
Jun 30, 2017 -43.61%
Mar 31, 2017 -2.50%
Dec 31, 2016 -21.16%
Sep 30, 2016 75.80%
Jun 30, 2016 5.38%
Mar 31, 2016 -5.94%
Dec 31, 2015 29.66%
Sep 30, 2015 11.43%
Jun 30, 2015 13.18%
Mar 31, 2015 45.46%
Dec 31, 2014 -11.46%
Sep 30, 2014 -28.47%
Jun 30, 2014 124.55%
Mar 31, 2014 399.47%
Dec 31, 2013 8.05%
Sep 30, 2013 -16.72%
Jun 30, 2013 59.43%
Mar 31, 2013 167.21%
Dec 31, 2012 18.71%
Sep 30, 2012 21.14%